Sold Out
Book Categories |
Contributors | ||
Preface | ||
1 | Cloning and Structure: Function Analysis of the Mouse mdr Gene Family | 5 |
2 | Functional and Molecular Characterization of the Human Multidrug Transporter | 29 |
3 | Regulation of MDR Genes | 39 |
4 | Cytogenetic Manifestations of Multidrug Resistance | 49 |
5 | Chromosomal and Extrachromosomal Localization of Human MDR Genes | 73 |
6 | MRP, Mode of Action and Role in MDR | 95 |
7 | Role of LRP/Major Vault Protein in Multidrug Resistance | |
8 | DNA Topoisomerase I Inhibitors and Multidrug Resistance | 119 |
9 | The Role of Topoisomerase II in Multidrug Resistance | 137 |
10 | Glutathione and Glutathione-associated Enzymes in Multidrug Resistance | 151 |
11 | Oncogenes and Tumor Suppressor Genes in Multidrug Resistance | 177 |
12 | Drug Sensitivity Genes: Identification and Analysis Using the Genetic Suppressor Element Approach | 193 |
13 | Changes in Membrane Ionic Conductances Associated with Multidrug Resistance | 219 |
14 | Identification and Characterization of the Drug-binding Sites of P-glycoprotein | 231 |
15 | Phosphorylation of Proteins Involved in Multidrug Resistance | 251 |
16 | Protein Kinase C and its Isozymes in Multidrug Resistance | 263 |
17 | Non-PKC Kinases and Multidrug Resistance | 273 |
18 | P-glycoprotein Expression in Normal Human Tissues | 285 |
19 | P-glycoprotein in the Normal Hematopoietic Progenitors and Cells of the Immune System | 293 |
20 | Role of P-glycoprotein in the Transport of Hormones and Peptides | 303 |
21 | Role of P-glycoprotein in the Blood-Brain Barrier | 321 |
22 | Transport of P-glycoprotein-modifying Agents by P-glycoprotein | 331 |
23 | Mice with Disrupted P-glycoprotein Genes | 345 |
24 | Molecular Pharmacology of Reversal of Multidrug Resistance and its Clinical Implications | 361 |
25 | Multidrug Resistance-reversing Agents for Potential Clinical Use | 375 |
26 | Cyclosporins and Related Fungal Products in the Reversal of P-glycoprotein-mediated Multidrug Resistance | 385 |
27 | Oligonucleotide Modulation of Multidrug Resistance Gene Expression | 413 |
28 | Application of the MDR1 Gene for Human Gene Therapy | 435 |
29 | Reversal of MDR in Acute Leukemia and Non-Hodgkin's Lymphoma | 453 |
30 | Prognostic Significance and Reversal of MDR in Multiple Myeloma | 463 |
31 | Reversal of MDR in Solid Tumors | 473 |
Index | 493 |
Login|Complaints|Blog|Games|Digital Media|Souls|Obituary|Contact Us|FAQ
CAN'T FIND WHAT YOU'RE LOOKING FOR? CLICK HERE!!! X
You must be logged in to add to WishlistX
This item is in your Wish ListX
This item is in your CollectionMultidrug Resistance in Cancer Cells : Molecular, Biochemical, Physiological and Biological Aspects
X
This Item is in Your InventoryMultidrug Resistance in Cancer Cells : Molecular, Biochemical, Physiological and Biological Aspects
X
You must be logged in to review the productsX
X
X
Add Multidrug Resistance in Cancer Cells : Molecular, Biochemical, Physiological and Biological Aspects, The emergence of resistant cancer cells after repeated courses of chemotherapy is exacerbated by the development of multidrug resistance and has reduced the promise of combination chemotherapy. This book considers the clinical and scientific implications , Multidrug Resistance in Cancer Cells : Molecular, Biochemical, Physiological and Biological Aspects to the inventory that you are selling on WonderClubX
X
Add Multidrug Resistance in Cancer Cells : Molecular, Biochemical, Physiological and Biological Aspects, The emergence of resistant cancer cells after repeated courses of chemotherapy is exacerbated by the development of multidrug resistance and has reduced the promise of combination chemotherapy. This book considers the clinical and scientific implications , Multidrug Resistance in Cancer Cells : Molecular, Biochemical, Physiological and Biological Aspects to your collection on WonderClub |